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A growing number of people are surviving into old 
age, with an associated increase in the prevalence of 
dementia.[1] It has been postulated that up to 80% of 
cases remain undiagnosed,[2] which has resulted in a call 
for dementia to be regarded as a global health priority.[3] 
The accurate detection of cognitive deficits due to dementia and 
mild cognitive impairment (MCI), a predementia stage, is important 
to distinguish these from normal age-associated cognitive deficits. 
Delaying the progression from MCI to dementia by even 1 year has 
been shown to result in significant cost savings.[4]
The absence of reliable, universally acceptable biological and 
radiological markers for dementia necessitates the reliance on 
clinical assessments for a diagnosis,[5] supported by the assessment 
of cognitive disturbances using a range of screening tests. The use 
of neuropsychological screening tests allows for the assessment of 
specific cognitive domains, can distinguish age-related cognitive 
deficits from those due to MCI or dementia, and is superior to brief 
cognitive tools for which floor and ceiling effects threaten their 
validity.[6,7] There is currently no universally accepted battery of tests 
for MCI[8,9] and the functioning of neuropsychological tests in low-
resource residential settings in South Africa (SA) has not been widely 
tested.
The objective of this study was to determine the sensitivity and 
specificity of a battery of neuropsychological tests in a sample of 
elderly persons living in a residential setting in SA. 
Methods
The research was conducted from 2010 to 2011, on residents aged 
≥60 years (N=1 371) in a group of residential homes in Durban, 
KwaZulu-Natal Province, SA. The homes are administered by a non-
governmental organisation and cater for those needing frail care, 
assisted living and independent living. Inclusion criteria for the study 
were: randomly selected residents ≥60 years; with a minimum of 8 years 
of formal schooling; the ability to speak, read and write in English; 
and the ability to give written, informed consent. Exclusion criteria 
were severe physical, mental or sensory handicaps that precluded 
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engagement in the assessment procedures. 
The study comprised three stages of cognitive 
assessments, conducted sequentially. In stage 
one, a random sample (n=302) of residents 
aged ≥60 years was selected based on a 
statistical calculation from all the homes. The 
Mini-Mental State Examination (MMSE),[10] 
a subjective memory rating scale,[11] and an 
informant questionnaire, the Deterioration 
Cognitive Observée (DECO)[12] were used to 
screen for dementia.[13] The sample size was 
calculated on a sensitivity and specificity of 
85% for the MMSE[14] and a conservative 
estimate of 20% prevalence for dementia in 
residential homes, based on the reported 
ranges of 16%[15] to 75%. [16] In stage two, 140 
participants from stage one, including MMSE 
screen positives and a random selection 
of MMSE screen negatives, were clinically 
assessed by psychiatrists and categorised as 
having dementia, MCI or not being clinically 
cognitively impaired.[17] Diagnostic and 
Statistical Manual of Mental Disorders, 4th 
edition (text revised) criteria A and B for 
Alzheimer’s and vascular dementia were used 
to assign a general diagnosis of dementia 
without reference to aetiology.[18] MCI was 
diagnosed using the criteria contained 
in the report of the International Working 
Group on mild cognitive impairment.[19] In 
stage 3, 140 participants from stage 2 were 
available and consented to the administration 
of a neuropsychological battery of tests. Of 
these, 2 participants died during the study 
and 20 either refused or were unavailable to 
participate. One person was unable to complete 
any of the neuropsychological tests and was 
excluded from the dataset. Of the remaining 
117 participants, 9 were participants with a 
diagnosis of dementia, 30 with MCI and 78 
participants did not meet diagnostic criteria 
and were classified as controls. 
The overall study was approved by the 
Biomedical Research Ethics Committee of the 
University of KwaZulu-Natal, with residents 
providing written, informed consent to 
participate.
Neuropsychological tests
Eleven neuropsychological measures (including 
29 tests) were administered by clinical psycho-
logists in English in a single session at the 
participants’ residences. The tests were: Rey 
auditory verbal learning tests (RAVLTs);[20] 
digit span[20] and digit symbol;[20] controlled 
oral word association test (COWAT F-A-S and 
Animal);[20] short story comprehension and 
recall (using an SA adaptation of the cowboy 
story, i.e. ‘A Farmer from Transkei’); [20] the 
token test (short version);[20] Rey complex figure 
(RCF); [20] trail making tests A and B (TMT-A 
and -B); [20] the clock drawing test[21] (the free-
drawing version with the ‘10 past 11’ time setting 
instruction using Rouleau’s 10-point scoring 
system);[22] the Luria hand sequence;[20] and the 
Maze test.[20] The psychologists were blind to 
the participants’ cognitive performances in the 
previous phases of the study.
Data analysis
Data were analysed using IBM SPSS 
(version 21.0) and MedCalc (version 12.5.0). 
Descriptive statistics were calculated for 
demographic variables, and mean neuro-
psychological scores and 95% confidence 
intervals (CIs) were calculated for each of the 
classified groups. Between-group comparisons 
were undertaken using non-parametric 
Kruskal-Wallis independent samples tests 
and Pearson’s χ2 tests or Fisher’s exact tests 
where appropriate. Between-group tests were 
not analysed by race due to the low number of 
black participants (n=4). Individual test random 
operating curve (ROC) analysis was conducted 
for discrimination validity and diagnostic 
accuracy of the different tests for dementia 
(n=9) v. non-dementia participants (controls 
and MCI cases; n=108) and for controls (n=78) 
and MCI participants (n=30), respectively. For 
each test, the area under the curve (AUC) was 
calculated with 95% CIs. Swet’s interpretation 
of AUC scores was used in this study: 0.5 
= non-informative; 0.5<AUC≤0.7 = less 
accurate; 0.7<AUC≤0.9 = moderately accurate; 
0.9<AUC<1 = highly accurate; and the 
perfect test has an AUC = 1. [23] Optimal cut-
off scores based on the Youden index and the 
associated sensitivity and specificity values 
were generated and ranked as significant 
tests for dementia and for MCI identification, 
respectively. 
Results
The average years of education of the 117 
par ticipants was 10.1 (standard deviation 
(SD) 2.2) years, with 87 (74.4%) reporting 
8 - 11 years of formal education (Table 1). 
English was the first language for 103 (88.0%) 
of the participants, followed by Afrikaans 
(n=6; 5.1%), isiZulu (n=4; 3.4%), and 
other languages (n=4; 3.4%). Most of the 
participants were female (n=82; 70.1%). The 
mean (SD) age was 74.2 (7.5) years, with 
significant differences between the three 
groups by race and age (Table 1). 
Cognitive deficits by diagnostic groups 
and controls 
Across the three classification categories, the 
differences in score means of the RAVLT 
(total), digit symbol (90 s), and COWAT 
Animal were highly significant, with p<0.001. 
With the exception of the digit span (forward), 
digit span total, COWAT A, narrative memory 
test (delayed recall), token test and the Luria 
hand sequence test, there were significant 
mean differences between all other tests in 
the three groups (Table 2). The mean score 
on most tests demonstrated a progressive 
declining pattern in cognitive performance 
ARTICLE
Table 1. Demographic data per diagnostic group 
Demographics Controls 
(n=78) 
MCI
(n=30) 
Dementia
(n=9) 
Statistic p-value
Age (years), mean (SD)* 72.1 (6.7) 76.4 (8.4) 79.0 (7.5) K=10.1 0.006†
Education (years), mean (SD)* 10.3 (2.2) 9.3 (1.6) 10.1 (2.2) K=5.8 0.055
Gender, n (%)‡
Female
Male
51 (65.4)
27 (34.6)
23 (76.7)
7 (23.3)
8 (88.9)
1 (11.1)
χ2=2.6 0.260
Race, n (%)‡
Asian
Black
Coloured
White
18 (23.1)
2 (2.6)
22 (28.2)
36 (46.2)
5 (16.7)
1 (3.3)
13 (43.3)
11 (36.7)
0 (0)
1 (11.1)
0 (0)
8 (88.9)
χ2=12.5 0.015*
* Age and years of education were compared using independent samples (Kruskal-Wallis tests). 
† Significance was set at p<0.05.
‡ Gender and race were compared using Pearson χ2 and Fisher’s exact tests where appropriate.
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from the control group to MCI to dementia subjects. The exceptions 
to this pattern were on digit span total (no difference in mean scores 
between MCI (12.2) and dementia (12.2) (p=0.066) and the COWAT 
group, where the mean dementia group scores were slightly better than 
the MCI group scores, with COWAT F (5.5 v. 4.6; p=0.010), COWAT A 
(3.8 v. 3.0; p=0.102), COWAT S (5.5 v. 5.4; p=0.011) and COWAT Total 
(14.4 v. 12.4; p=0.002). Similarly, for the RCF (copy), the MCI score 
(40.4) was better than that of the controls (30.7) (p=0.017). 
Discrimination validity: Dementia v. non-dementia 
participants
Using individual ROC curves to measure how well the tests 
discriminated between participants with dementia and without 
dementia (participants with MCI and controls), AUCs ranged 
from  0.519 for digit span (forward) to 0.828 for digit symbol (90 
s). Fifteen of the 29 tests achieved a significant difference, with 
p<0.001 demonstrated on the RAVLT trial II (AUC = 0.753), RAVLT 
Table 2. Mean test scores per diagnostic groups and controls
Test Control mean (95% CI) 
(n=78) 
MCI mean (95% CI) 
(n=30) 
Dementia mean (95% CI) 
(n =9) 
K-Statistic* p-value
RAVLT
Trial I 4.8 (4.4 - 5.2) 4.2 (3.4 - 4.9) 3.3 (1.9 - 4.8) 6.6 0.037†
Trial II 6.8 (6.2 - 7.4) 5.8 (5.1 - 6.6) 4.6 (3.4 - 5.7) 10.2 0.006†
Trial III 7.9 (7.3 - 8.5) 6.9 (5.9 - 7.8) 5.2 (4.0 - 6.5) 11.2 0.004†
Trial IV 8.6 (8.0 - 9.3) 7.0 (6.1 - 8.0) 5.6 (3.8 - 7.3) 14.2 0.001†
Trial V 9.1 (8.5 - 9.8) 7.7 (6.7 - 8.8) 5.4 (3.6 - 7.30) 14.5 0.001†
Trials I - V 37.3 (34.8 - 39.8) 31.6 (27.6 - 35.6) 24.1 (18.8 - 29.5) 15.4 <0.001†
Immediate recall 6.6 (5.8 - 7.5) 5.5 (4.4 - 6.7) 3.1 (0.9 - 5.3) 9.6 0.008†
20 min recall 6.0 (5.1 - 6.0) 5.0 (3.9 - 6.1) 2.6 (0.5 - 4.70) 6.9 0.032†
Digit span
Forward 9.0 (8.5 - 9.5) 7.8 (7.0 - 8.6) 8.4 (7.0 - 9.9) 5.9 0.052
Backward 5.0 (4.6 - 5.5) 4.2 (3.6 - 4.9) 3.8 (2.9 - 4.7) 7.2 0.028†
Total 14.0 (13.2 - 14.9) 12.2 (10.9 - 13.5) 12.2 (10.0 - 14.5) 5.4 0.066
Digit symbol
90 s 25.9 (23.5 - 28.2) 20.0 (17.2 - 22.8) 12.9 (7.3 - 18.5) 17.0 <0.001†
120 s 31.9 (28.3 - 35.5) 25.5 (21.9 - 29.1) 13.9 (3.5 - 24.3) 13.4 0.001†
COWAT
F 6.8 (5.9 - 7.7) 4.6 (3.4 - 5.7) 5.1 (2.8 - 7.5) 9.3 0.010†
A 4.2 (3.5 - 4.9) 3.0 (2.0 - 4.0) 3.8 (1.8 - 5.7) 4.5 0.102
S 7.6 (6.7 - 8.4) 5.4 (4.1 - 6.8)* 5.5 (3.2 - 7.8) 9.1 0.011†
Total 18.5 (16.4 - 20.7) 12.4 (9.5 - 15.4) 14.4 (8.6 - 20.1) 12.2 0.002†
Animal 11.9 (10.9 - 12.8) 8.1 (6.7 - 9.6) 6.5 (2.8 - 10.2) 22.2 <0.001†
Narrative recall 8.1 (7.0 - 9.2) 7.1 (5.9 - 8.3) 4.4 (1.4 - 7.5) 6.2 0.045†
Narrative delayed recall 6.8 (5.8 - 7.9) 5.8 (4.4 - 7.3) 3.6 (0.3 - 6.8) 4.8 0.090
Token test 162.7 (159.2 - 166.2) 153.0 (143.9 - 162.1) 147.1 (124.5 - 169.7) 5.5 0.064
RCF
Copy 30.7 (29.2 - 32.2) 40.4 (19.1 - 61.7) 21.2 (12.6 - 29.7) 8.2 0.017†
Recall 13.5 (11.8 - 15.3) 10.7 (8.7 - 12.7) 7.7 (2.3 - 13.1) 7.1 0.028†
Delayed 14.1 (12.5 - 15.8) 11.0 (8.9 - 13.2) 6.3 (0.7 - 11.9) 11.6 0.003†
Clock drawing 8.7 (8.4 - 9.1) 8.5 (7.7 - 9.3) 6.7 (4.5 - 8.9) 6.1 0.047†
Luria hand sequence 2.5 (2.2 - 2.8) 2.3 (1.8 - 2.9) 1.9 (0.2 - 3.5) 1.3 0.530
TMT
A 70.8 (62.2 - 79.4) 82.4 (70.8 - 4.1) 86.3 (60.6 - 11.9) 8.4 0.015†
B 154.6 (138.2 - 171.0) 195.1 (167.6 - 222.6) 290.1 (105.1 - 475.1) 10.4 0.005†
Maze total 385.1 (344.1 - 426.1) 521.7 (440.7 - 602.7) 571.1 (312.3 - 830.0) 10.5 0.005†
CI = confidence interval; RAVLTs = Rey auditory verbal learning tests; COWAT = controlled oral word association test; RCF = Rey complex figure; TMT = trail making test.
*Tests were compared using independent sample Kruskal-Wallis (K) tests. 
†Significance level was set at p<0.05 and 95% CIs. 
August 2014  Vol. 20  No. 3    -  SAJP    97
article
trial III (AUC = 0.775), RAVLT trial V 
(AUC = 0.812), RAVLT total (AUC = 0.805), 
RAVLT immediate recall (AUC = 0.770), 
RAVLT 20 min recall (AUC = 0.741), digit 
symbol (90 s) (AUC = 0.828), digit symbol 
(120 s) (AUC = 0.804) and RCF copy (AUC = 
0.783) (Table 3).
The 15 significant tests were ranked, based 
on optimum balance between sensitivity and 
specificity (Fig. 1). The most balanced test was 
the digit symbol, with a sensitivity of 87.5% 
and specificities of 80.6% at 90 s and 75.0% 
at 120 s, with cut-off scores of <15 and <20, 
respectively. Although the RAVLT trial III and 
the RAVLT total had the best discrimination 
sensitivity (100% at cut-off scores <7 and <34), 
this was at the expense of their specificities, 
which were 50.0% and 50.9%, respectively. 
Discrimination validity: MCI v. control 
participants
Using individual ROC curves to measure 
how well the tests discriminated between 
participants with MCI and controls, 17 of the 
29 tests achieved a significant AUC (p<0.05) 
(Table 4). AUCs ranged from 0.621 to 0.754, 
with significance levels of p<0.001 on the digit 
symbol (90 s), COWAT F, COWAT Total, 
and COWAT Animal. 
The 17 significant tests were ranked, based 
on optimum balance between sensitivity 
and specificity (Fig. 2). The most balanced 
subtest score, the RCF (delayed recall), had 
a sensitivity of 77.8% and specificity of 
76.9%, at a cut-off score of ≤14. The highest 
sensitivity reported was 93.3%, which was 
for digit span (backwards) and digit symbol 
(120 s), at cut-off scores of ≤5 and ≤36, 
respectively, with the highest specificity 
being 83.3% (Maze total), at a cut-off score 
of >544. 
Discussion 
This research sought to determine the sensi-
tivity and specificity of a battery of neuro-
psychological tests in elderly participants 
from a low-resource residential setting, who 
were diagnosed with MCI and dementia. 
While the tests used have been widely 
researched, to our knowledge, this is the first 
time that their diagnostic discriminability 
was evaluated in a heterogeneous elderly 
SA population. The findings are discussed 
in terms of screening for overall cognitive 
decline, dementia and MCI.
Screening for overall pathological 
cognitive decline 
With the exception of recall on the narrative 
memory test and the token test, all the 
tests were able to significantly discriminate 
between controls and those with clinically 
significant cognitive impairment (dementia 
or MCI). The token test was found to be of 
little value, in keeping with previous research 
that found that the token test ceiling effects 
limited its utility.[24]
The data from this research supported 
the conclusion that the clock drawing 
test has value for screening moderate-
to-severe cognitive impairment, but is 
relatively poor at detecting milder forms 
of cognitive impairment.[25] The clock 
drawing test has been described as the ideal 
cognitive screening test owing to its ease 
Table 3. ROC analysis for tests for dementia v. non-dementia
Test AUC (95% CI) p-value Cut-off Sensitivity Specificity
RAVLT
Trial I 0.670 (0.577 - 0.754) 0.095 ≤2 44.4 88.9
Trial II 0.753 (0.665 - 0.828) <0.001* ≤5 77.8 61.1
Trial III 0.775 (0.688 - 0.847) <0.001* ≤7 100 50.9
Trial IV 0.757 (0.669 - 0.832) <0.001* ≤7 88.0 57.6
Trial V 0.812 (0.729 - 0.878) <0.001* ≤7 88.9 61.1
Total trials I - V 0.805 (0.721 - 0.872) <0.001* ≤34 100 50.0
Immediate recall 0.770 (0.683 - 0.842) <0.001* ≤4 77.8 68.5
20 min recall 0.741 (0.652 - 0.817) <0.001* ≤5 88.9 51.9
Digit span
Forward 0.519 (0.424 -0.612) 0.835 ≤8 66.7 53.7
Backward 0.646 (0.552 - 0.732) 0.094 ≤5 100.0 24.1
Total 0.549 (0.454 - 0.641) 0.600 ≤15 100.0 25.0
Digit symbol
90 s 0.828 (0.746 - 0.891) <0.001* ≤15 87.5 80.6
120 s 0.804 (0.720 - 0.872) <0.001* ≤20 87.5 75.0
COWAT
F 0.561 (0.466 - 0.654) 0.557 ≤4 50.0 56.4
A 0.530 (0.434 - 0.624) 0.787 >4 50.0 69.2
S 0.595 (0.500 - 0.685) 0.308 ≤9 100 26.9
Total 0.552 (0.456 - 0.644) 0.622 ≤23 100 20.4
Animal 0.763 (0.675 - 0.837) 0.017* ≤4 50.0 96.3
Narrative recall 0.736 (0.646 - 0.813) 0.011* ≤6.0 88.9 62.0
Narrative delayed recall 0.693 (0.601 - 0.775) 0.050 ≤0 44.4 88.0
Token test total 0.650 (0.557 - 0.736) 0.180 ≥162 77.8 63.0
RCF
Copy 0.783 (0.698 - 0.854) <0.001* ≤21 55.6 89.8
Recall 0.709 (0.618 - 0.790) 0.039* ≤7 66.7 75.9
Delayed 0.781 (0.696 - 0.852) 0.005* ≤8 77.8 76.9
Clock drawing 0.732 (0.642 - 0.810) 0.012* ≤5 44.4 91.7
Luria hand sequence 0.600 (0.505 - 0.690) 0.448 ≤1 50.0 75.0
TMT
A 0.669 (0.575 - 0.754) 0.141 >72 75.0 62.6
B 0.669 (0.575 - 0.754) 0.143 >210 62.5 76.4
Maze total 0.641 (0.546 - 0.728) 0.130 >329 100.0 34.3
ROC = random operating curve; AUC = area under the curve; CI = confidence interval; RAVLT = Rey auditory verbal learning tests; 
COWAT = controlled oral word association test; RCF = Rey complex figure; TMT = trail making test.
* Significance level set as p<0.05 and 95% CIs. 
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of administration and scoring, its ability 
to assess a range of cognitive abilities and 
good psychometric properties.[26,27] While 
it has shown good correlation with the 
Mini-Mental State Examination (MMSE),[26] 
it has also shown moderate sensitivity and 
specificity in detecting executive dysfunction 
in patients who have a normal MMSE.[28] 
In this study, the clock drawing test, with 
an AUC of 0.732, supported its utility as 
a dementia assessment[27] and confirmed 
earlier findings of its ability to differentiate 
normal from pathological cognitive decline.
[29] However, the sensitivity of 44.4% in this 
study was much lower than the mean of 
85% reported in the literature for dementia 
screening, while the specificity of 91.7% 
compared favourably with the specificity of 
85% reported in the literature.[26]
Screening for dementia
Memory disturbances are one of the most 
common cognitive complaints in the elderly, 
and can be attributed to either normal decline 
associated with ageing or dementia.[30] In 
this research, the RAVLTs demonstrated the 
best discrimination validity for dementia, 
thus confirming their utility in diagnosing 
the disorder. With the exception of trial 
I of the RAVLTs, all the RAVLT subtest 
measures displayed significance at p<0.001. 
These tests are brief tests of memory function 
that are easy to administer and sensitive to 
encoding, storage and retrieval of memory.
[31] This finding is consistent with those of 
previous studies, showing that the RAVLTs 
are useful in distinguishing participants with 
dementia from those in a control group.
[32] Some studies have also shown that the 
RAVLTs are useful in distinguishing normal 
participants from those with dementia 
associated with Alzheimer’s disease and 
vascular dementia,[32,33] and that the RAVLTs 
are also able to predict the conversion to 
dementia in those individuals with subjective 
memory complaints[32] and MCI.[33]
However, the most balanced test was found 
to be the digit symbol (p<0.001), which 
measures attention and working memory. 
The mean scores on the digit symbol 
(90 s) in the study were lower than those 
reported by Hart et al.,[33] which may be 
owing to the lower mean education level of 
participants; education level is reported to 
affect performance on the digit symbol test. 
These findings suggest that the memory 
deficits evident by the RAVLT scores may 
be attributable to storage and retrieval 
difficulties, as the digit symbol test is more 
demanding of attention and concentration 
consistent with the graded deterioration of 
cognitive functions in dementia. 
Two other tests useful for screening of 
dementia and consistent with other studies 
Fig. 1. Optimal sensitivity and specificity of tests for dementia v. non-dementia. (RAVLT = Rey auditory verbal 
learning tests; RCF = Rey complex figure; COWAT = controlled oral word association test.)
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Fig. 2. Optimal sensitivity and specificity of tests for MCI v. controls. (COWAT = controlled oral word 
association test; RCF = Rey complex figure; TMT = trail making test; MCI = mild cognitive impairment.)
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were the RCF[34] and COWAT Animal.[35,36] 
The RCF findings were similar to a study 
that showed that it was able to distinguish 
patients with Alzheimer’s disease and 
vascular dementia from those in the control 
group. [34] The COWAT semantic fluency 
(‘animal’) category displayed diagnostic 
significance for dementia (p=0.017), whereas 
phonological fluency (FAS) did not. The 
superiority of semantic fluency over other 
verbal fluency measures has been shown in 
SA[35] and elsewhere.[36] The animal category 
is also simple to administer and interpret, 
and could be valuable as a screening and/or 
diagnostic measure for use in low-income 
country settings. 
Although the TMT is a popular 
neuropsychological test and is included in 
most test batteries, in this study the TMT 
did not significantly discriminate dementia 
from non-dementia participants. However, 
this finding may be owing to the non-clinical 
sample in this study, as neuropsychological 
tests are considered to be less accurate in 
community samples.[29] 
Screening for MCI
MCI is widely regarded as an intermediate 
stage between Alzheimer’s disease and 
normal ageing, and has a heterogeneous 
cognitive profile.[37,38] It is therefore 
recommended that an extensive range of 
domains be covered when assessing for 
MCI, including language, memory, executive 
functions and attention.[9,38] Several tests 
displayed significant diagnostic accuracy for 
MCI, namely digit symbol (90 s), COWAT F, 
FAS Total and Animal, and the TMT-B, 
with the highest sensitivity reported for digit 
span (backwards), digit symbol (120 s), and 
Maze total. The most balanced test was the 
RCF (delayed recall). The findings showed a 
similarity to the Goteborg MCI study,[38] with 
significantly low scores on memory, attention 
and working memory, and visuospatial and 
executive functions. 
Compared with the profile of tests that 
were significant for dementia, the language 
tests (COWAT F-A-S, Total and Animal) and 
the working memory/attention tests (digit 
span) showed little overlap, suggesting that 
in this sample at least, MCI and dementia 
may represent different clinical entities 
rather than MCI being a milder or earlier 
stage of dementia. Our findings therefore 
validate MCI as a distinct clinical entity that 
is distinguishable, with neuropsychological 
testing, from age-related and dementia-
associated cognitive decline.
Study limitations
The lack of stratification of the sample per 
demographic variables reviewed (race, gender, 
age, education), the small number of dementia 
cases and the specificity of the residential setting 
limited the generalisability of our findings. 
Though the sample reflected the population of 
the residential homes, it did not represent all 
race groups in the SA community adequately. 
In view of the confounding effects of culture 
on test performance, it is recommended that 
this research is repeated with a large sample 
of black African participants. As the ability 
to speak English was required for eligibility 
Table 4. ROC analysis tests for MCI v. controls
Test AUC (95% CI) p-value Cut-off Sensitivity Specificity
RAVLT
Trial I 0.618 (0.519 - 0.709) 0.061 ≤4 70.0 53.9
Trial II 0.621 (0.523 - 0.713) 0.037* ≤5 53.3 66.7
Trial III 0.618 (0.520 - 0.710) 0.051 ≤7 63.3 56.4
Trial IV 0.671 (0.574 - 0.759) 0.002* ≤8 76.7 53.9
Trial V 0.639 (0.541 - 0.729) 0.019* ≤8 66.7 56.4
Total trials I - V 0.657 (0.559 - 0.745) 0.009* ≤29 56.7 76.9
Immediate recall 0.599 (0.501 - 0.692) 0.097 ≤7 76.7 42.3
20 min recall 0.568 (0.470 - 0.663) 0.229 ≤7 86.7 37.2
Digital span
Forward 0.646 (0.549 - 0.736) 0.011* ≤9 86.7 43.6
Backward 0.635 (0.537 -0.726) 0.014* ≤5 93.3 30.8
Total 0.638 (0.540 - 0.728) 0.016* ≤14 86.7 39.7
Digit symbol
90 s 0.677 (0.580 - 0.764) <0.001* ≤27 83.3 46.2
120 s 0.649 (0.551 - 0.738) 0.005* ≤36 93.3 42.3
COWAT
F 0.685 (0.588 - 0.771) <0.001* ≤6 83.3 45. 5
A 0.631 (0.532 - 0.722) 0.027* ≤3 73.3 52.0
S 0.676 (0.579 - 0.763) 0.002* ≤4 56.7 71.8
Total 0.714 (0.619 - 0.797) <0.001* ≤12 66.7 70.5
Animal 0.754 (0.662 - 0.832) <0.001* ≤10 76.7 62.8
Narrative recall 0.557 (0.459 - 0.653) 0.307 ≤12 96.7 23.1
Narrative delayed recall 0.566 (0.467 - 0.661) 0.251 ≤8 80.0 39.7
Token test total 0.611 (0.512 - 0.703) 0.089 ≤156 46.7 79.5
RCF
Copy 0.507 (0.409 - 0.604) 0.918 >28 73.3 21.8
Recall 0.603 (0.505 - 0.696) 0.062 ≤13 76.7 46.1
Delayed 0.631 (0.533 - 0.722) 0.023* ≤14 76.7 50.0
Clock drawing 0.506 (0.408 - 0.604) 0.922 ≤5 16.7 94.9
Luria hand sequence 0.537 (0.438 - 0.633) 0.547 ≤3 80.0 28.2
TMT
A 0.655 (0.557 - 0.744) 0.006 >64 73.3 54.6
B 0.679 (0.581 - 0.766) 0.001* >159 66.7 65.8
Maze total 0.685 (0.588 - 0.771) 0.002* >544 46.7 83.3
ROC = random operating curve; AUC = area under the curve; CI = confidence interval; RAVLT = Rey auditory verbal learning tests; 
COWAT = controlled oral word association test; RCF = Rey complex figure; TMT = trail making test.
* Significance level set at p<0.05 and 95% CIs. 
100    SAJP  -  August 2014  Vol. 20  No. 3 
article
to participate in the study, the confounding effects of language cannot 
be excluded, as English was not the first language of all participants. 
Further, the discrimination capacity of the tests for dementia may 
have been diminished by the inclusion of MCI participants in the 
comparison group, inflating the mean test scores of the non-dementia 
group. 
Conclusion
A recommended neuropsychological test battery can be used 
effectively either to screen for or discriminate between early and 
later stages of cognitive impairment in the elderly. However, in line 
with the Jacova[7]’s evidence-based review, it is recommended that 
neuropsychological tests should not be used alone for diagnostic 
purposes; they should be part of a clinically integrative process, used 
selectively to aid in distinguishing normal age-related cognition from 
MCI and early dementia, for the differential diagnosis of cognitive 
impairment and possibly for assessing the risk of progression from 
MCI to dementia.[7]
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